Weerakoon-Ratnayake Kumuditha M, O'Neil Colleen E, Uba Franklin I, Soper Steven A
Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC 27599, USA and NIH Biotechnology Resource Center of Biomodular Multiscale Systems for Precision Medicine, USA.
Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA and NIH Biotechnology Resource Center of Biomodular Multiscale Systems for Precision Medicine, USA.
Lab Chip. 2017 Jan 31;17(3):362-381. doi: 10.1039/c6lc01173j.
Microfluidics is now moving into a developmental stage where basic discoveries are being transitioned into the commercial sector so that these discoveries can affect, for example, healthcare. Thus, high production rate microfabrication technologies, such as thermal embossing and/or injection molding, are being used to produce low-cost consumables appropriate for commercial applications. Based on recent reports, it is clear that nanofluidics offers some attractive process capabilities that may provide unique venues for biomolecular analyses that cannot be realized at the microscale. Thus, it would be attractive to consider early in the developmental cycle of nanofluidics production pipelines that can generate devices possessing sub-150 nm dimensions in a high production mode and at low-cost to accommodate the commercialization of this exciting technology. Recently, functional sub-150 nm thermoplastic nanofluidic devices have been reported that can provide high process yield rates, which can enable commercial translation of nanofluidics. This review presents an overview of recent advancements in the fabrication, assembly, surface modification and the characterization of thermoplastic nanofluidic devices. Also, several examples in which nanoscale phenomena have been exploited for the analysis of biomolecules are highlighted. Lastly, some general conclusions and future outlooks are presented.
微流控技术目前正进入一个发展阶段,基础研究成果正在向商业领域转化,以便这些成果能够影响,例如,医疗保健领域。因此,诸如热压印和/或注塑成型等高生产率微制造技术正被用于生产适用于商业应用的低成本耗材。根据最近的报告,很明显,纳米流体学提供了一些有吸引力的工艺能力,可能为生物分子分析提供在微尺度上无法实现的独特途径。因此,在纳米流体学生产管道的开发周期早期考虑能够以高产量模式且低成本制造尺寸小于150纳米的器件,以适应这项令人兴奋的技术的商业化,将是很有吸引力的。最近,已报道了功能性小于150纳米的热塑性纳米流体器件,其能够提供高工艺成品率,这可以推动纳米流体学的商业转化。本综述概述了热塑性纳米流体器件在制造、组装、表面改性和表征方面的最新进展。此外,还重点介绍了利用纳米尺度现象分析生物分子的几个实例。最后,给出了一些一般性结论和未来展望。